Application Information

This drug has been submitted to the FDA under the reference 022321/001.

Names and composition

"EMBEDA" is the commercial name of a drug composed of MORPHINE SULFATE and NALTREXONE HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022321/001 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 20MG and 0.8MG
022321/002 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 30MG and 1.2MG
022321/003 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 50MG and 2MG
022321/004 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 60MG and 2.4MG
022321/005 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 80MG and 3.2MG
022321/006 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 100MG and 4MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022321/001 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 20MG and 0.8MG
022321/002 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 30MG and 1.2MG
022321/003 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 50MG and 2MG
022321/004 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 60MG and 2.4MG
022321/005 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 80MG and 3.2MG
022321/006 EMBEDA MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE/ORAL 100MG and 4MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved